NCT03037671View on ClinicalTrials.gov

Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

February 9, 2017

Primary Completion Date

January 17, 2020

Study Completion Date

April 4, 2024

Conditions
Hematopoietic Stem Cell Transplantation
Interventions
DEVICE

Continuous Glucose Monitor (CGM)

Participants will wear the continuous glucose monitor (GCM) device during the peri-HSCT period for the duration of their initial hospital admission. No intervention based on results.

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT03037671 - Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population | Biotech Hunter | Biotech Hunter